Skip to content
lifestyle.mmminimal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SAB Biotherapeutics, Inc.
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
March 10, 2026
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
March 9, 2026
SAB BIO to Participate in Upcoming Investor Conferences
March 2, 2026
SAB BIO to Participate in Upcoming Investor Conferences
February 10, 2026
←
Previous Page
1
2